What you need to know about the follow-on biologic market in the U.S.

The trend toward biologics development in the United States has been apparent. The total number of reported clinical trials with a biological intervention between 2000 and 2005 was 1,197. In the following five years, the total increased to almost 6,000. Additionally, as of November 2010, only 3 percent of reported Phase III candidates in U.S.clinical studies indicated a..